Inflammatory disease therapy : preclinical and clinical developments
著者
書誌事項
Inflammatory disease therapy : preclinical and clinical developments
（Agents and actions supplements, v. 41）
Birkhäuser Verlag, c1993
- : sz
- : us
大学図書館所蔵 件 / 全4件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
"Sixth International Meeting, sponsored by the Inflammation Research Association held on September 20-24, 1992 in White Haven, Pennsylvania, focused on inflammatory disease therapy ..."--Pref
Includes bibliographical references
内容説明・目次
内容説明
The search for new drugs for inflammatory diseases currently centres on a number of questions. These include the role of biologics in the treatment of rheumatoid arthritis, the possible effectiveness of anti-inflammatory drugs in the treatment of asthma and the feasibility of developing neuropeptide inhibitors as analgesics. This volume focuses on recent preclinical and clinical advances in inflammatory disease research in lung inflammation, rheumatoid arthritis, ischemia/reprefusion injury and inflammatory pain. The chapters include the most recent results obtained from novel animal models, as well as new insights into the role of the adhesion of inflammatory cells to the endothelium and to other cells in connection with inflammatory diseases of the lung and joints.
目次
- Part 1 Plenary presentation: corticotropin releasing hormone and the hypothalamic-pituitary-adrenal axis in the regulation of inflammatory arthritis, R.L. Wilder. Part 2 Lung inflammation - are anti-inflammatory agents a therapeutic approach to asthma?: anti-inflammatory treatment in asthma - current deficiencies in therapy, C.P. Page
- beta2-agonists as anti-inflammatory therapies in the lung, M. Johnson
- control of inflammatory processes by adhesion glycoproteins, C.D. Wegner et al
- status of leukotriene antagonists and other modulators of lipid mediators, R.D. Krell. Part 3 Inflammatory pain - is there life after NSAIDs?: bradykinin and inflammatory pain, K.M. Hargreaves et al
- Substance P and inflammatory pain - potential of Substance P antagonists as analgesics, J.L. Henry
- spinal actions of NSAIDs in blocking spinally mediated hyperalgesia - the role of cyclooxygenase products, T.L. Yaksh and A.B. Malmberg. Part 4 Rheumatoid arthritis - what is the future of biologics in the therapy of RA?: L-Selectin-IgG chimera - in vitro and in vivo, S.R. Watson. Part 5 Ischemia/reperfusion injury - what is the role of inflammation in ischemia/reperfusion injury?: the role of adhesion molecules in reperfusion injury, R.K. Winn et al
- endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury, A.M. Lefer et al
- ischemia-reperfusion injury, A. Seekamp and P.A. Ward
- neutrophil-endothelial cell interactions in vivo - a chain of events characterized by distinct molecular mechanisms, U.H. von Andrian and K.-E. Arfors. Part 6 C. Gordon Van Arman Scholarship competition, R.P. Carlson. Part 7 Workshop sessions: novel aspects of lipid mediators, R.D. Dyer and L.A. Marschall
- osteoarthritis workshop, E.C. Arner and G. DiPasquale
- lung inflammation workshop, S. Silbaugh and W. Selig
- dermal inflammation workshop, R.R. Harris and K.M. Tramposch
- immunoregulation workshop, W.R. Benjamin and B. Jaffee
- regulation of cytokines workshop, S.A. Stimpson and P. Stevens
- drugs and lipid mediators, C. Lanni and D. Aharony
- tissue damage and repair workshop, R. Sturm and J.C. Williams.
「Nielsen BookData」 より
